Domo Health

What Domo Health does

Domo Health (多睦健康) is a private, Shanghai-headquartered cross-border medical service intermediary founded in 2016 that connects Chinese patients — primarily high-net-worth individuals and families — with advanced Japanese healthcare providers. The company's core offerings include precision health examinations (advertised to detect cancers as small as 5mm), DFPP blood purification, stem cell therapy for diabetes, arthritis, liver cirrhosis and anti-aging, immune cell therapy (including NK cell therapy), genetic testing, proton and heavy ion radiotherapy arrangement, remote consultation, and full-service medical treatment coordination in Japan.

Underlying assets include an exclusive partnership with Tokyo Midtown Medical Center (one of only three facilities in Japan publicly offering DFPP), a reported network of hundreds of Japanese partner hospitals, certified medical translation teams, and a Yokohama-based Japan operations office for on-ground coordination. The service workflow covers pre-trip consultation, hospital matching, appointment scheduling via a "green channel," medical translation, travel and accommodation, and post-treatment report interpretation.

Domo Health operates a fee-for-service professional services model with custom per-case pricing — clients contact the company directly (400-852-0285) for quotes rather than transacting on a published price list. Customer acquisition is sales-led, combining direct in-house sales across a six-city Chinese footprint (Shanghai HQ plus Beijing, Wuxi, Taiyuan, Fuzhou branches), referral partnerships with major Chinese wealth managers (Noah Wealth, Baoxin Real Estate, Tianan Group) and insurance groups (Ping An, Zhong'an, Changsheng Life), and content-driven demand generation through its website and WeChat platform. The company received a 2017 seed investment from Jiawo Capital and CCTV National Brand Documentary recognition, and has been led under the same privately-held structure since founding.

Name

Domo Health

Legal name

多睦健康 (Domo Health)

Website

https://domo-kenkou.com

Company type

Private

Founded year

2016

Operating status

Operating

Short description

Domo Health is a Shanghai-based private medical tourism intermediary founded in 2016 that arranges premium Japanese healthcare — precision exams, DFPP, stem cell and immune cell therapy — for Chinese high-net-worth individuals and families through exclusive hospital partnerships and a six-city China footprint.

Ownership category

akta.pro rank

Product category

Overseas Medical Tourism / Cross-Border Healthcare Services

SIC

Services-Health Services (8000)

akta.pro primary industry

International / Expat PPO Networks (HLAEANAM)

Keywords

• Overseas medical tourism
• Precision health examinations
• Stem cell therapy services
• Blood purification therapy
• Cross-border healthcare

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Overseas Medical Travel Services: Fee-for-service model where clients pay for personalized overseas medical services including precision health examinations, stem cell therapies, blood purification, immune cell therapies, and other treatments in Japan. Services are priced on a per-case basis based on the type of treatment and service package selected.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Domo Health is a cross-border medical tourism and health management intermediary that connects Chinese clients—primarily affluent individuals and families—with advanced Japanese healthcare services. The company delivers end-to-end, one-stop service packages covering precision health examinations, stem cell therapy, immune cell therapy, DFPP blood purification, genetic testing, proton/heavy ion radiotherapy, and treatment arrangement, including hospital matching, priority appointment scheduling, certified medical translation, travel and accommodation logistics, and post-treatment report interpretation.

Product overview

Domo Health (多睦健康) is a professional overseas medical service provider specializing in connecting Chinese patients with Japanese healthcare services. The company offers a comprehensive suite of medical tourism services including precision health examinations (精密体检) capable of detecting 5mm cancer cells, blood purification therapy (血液净化/DFPP), stem cell therapy (干细胞治疗), immune cell therapy (免疫细胞疗法), genetic testing (基因检测), remote consultations, and medical treatment coordination in Japan. The company serves as a one-stop-shop for high-end medical services, providing hospital matching, appointment scheduling, medical translation, travel arrangements, and interpretation services for Chinese patients seeking treatment at top Japanese medical institutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Precision Health Examination (精密体检) High-precision health examination services delivered at Japanese partner hospitals, capable of detecting cancer cells as small as 5mm with comprehensive screening covering over 300 types of cancer. Targeted at Chinese clients seeking early cancer detection that exceeds standard 15mm detection in China.
• Blood Purification Therapy (血液净化/DFPP) DFPP (Double Filtration Plasma Pheresis) blood purification therapy that separates blood plasma to remove harmful substances such as low-density lipoprotein cholesterol and triglycerides, then returns purified blood to the body. Used for treating high blood pressure, hyperlipidemia, diabetes, and cardiovascular disease prevention. Documented outcomes include triglyceride reduction from 1125 to ~600 in a single session (Li Zong case).
• Stem Cell Therapy (干细胞治疗) Stem cell therapy services including stem cell extraction, cultivation, and reinjection, applied across anti-aging, Type 2 diabetes, arthritis, liver cirrhosis, gum atrophy, stroke recovery, and other regenerative indications. Cases include Type 2 diabetic patients reducing insulin dependency to zero and gum tissue regeneration of approximately 25% within 3 months.
• Overseas Medical Treatment Arrangement (赴日就医) Medical treatment arrangement service in Japan that connects patients with top Japanese hospitals and specialists, providing appointment scheduling, certified medical translation, and travel coordination. Includes specialist consultations, second opinions, and inpatient coordination.
• Immune Cell Therapy (免疫细胞疗法) Immune cell therapy including NK cell therapy for cancer treatment and prevention, applied to enhance the body's immune system to fight cancer cells (e.g., for cancer survivors seeking recurrence prevention).
• Genetic Testing (基因检测) Genetic testing services that analyze DNA to assess disease risk, hereditary conditions, and personal health traits. Capable of detecting over 100 types of diseases including 31 types of malignant tumors and 18 types of cardiovascular diseases.
• Remote Specialist Consultation (远程会诊) Remote medical consultation services connecting Chinese patients with Japanese specialists for second opinions and treatment planning, often preceding physical travel to Japan.
• Proton and Heavy Ion Radiotherapy Arrangement (质子重离子治疗) Proton and heavy ion radiotherapy treatment arrangement services for cancer patients in Japan, connecting clients with Japanese proton therapy hospitals.

Quantifiable outcome

• Japan cancer 5-year survival rate reaches 81.6%, compared to 30.9% in China — enabling early detection through precision screening
• +3 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

24 partnerships are on record, tiered secondary, core and minor.

• Quanjing Medical Imaging (全景医学)secondaryTechnology or Integration · 1 May 2019Partnership with Quanjing Medical Imaging diagnostic center to provide precise medical imaging services for Domo Health clients, enhancing diagnostic accuracy before and after overseas treatment.
• Zhong'an Insurance (众安保险)coreStrategic or Co-development Partner · 21 January 2019Domo Health partnered with China's first internet-only insurance company to jointly launch a new health insurance product. Zhong'an provides insurance coverage while Domo Health delivers overseas medical management services including second opinions, specialist consultations, and高端精密体检.
• SOS International (国际救援组织)minorStrategic or Co-development Partner · 1 April 2018SOS International partnered with Domo Health in April 2018 to help clients realize their longevity aspirations through combined international medical assistance and premium overseas medical services.
• Premium Dental Clinic Chain (高端齿科诊所)minorStrategic or Co-development Partner · 1 February 2018Following collaboration with Arcari Dental, another chain of premium dental clinics partnered with Domo Health in February 2018 to provide comprehensive dental services to Domo Health clients.
• Bone and Joint New Medical (骨康新生医疗)minorStrategic or Co-development Partner · 10 January 2018Domo Health received personal meeting with Japan's top orthopedic expert, facilitating access to Japan's premier bone and joint treatments for Chinese patients.
• Baoxin Real Estate (宝信地产)secondaryGTM or Marketing Partner · 1 January 2018Baoxin Real Estate, a core business of Baoxin Holding (HK), partnered with Domo Health for cross-industry collaboration, bringing together real estate and medical tourism services for their high-end client base.
• Ping An Good Doctor (平安好医生)coreStrategic or Co-development Partner · 1 September 2017Strategic partnership with Ping An Good Doctor under Ping An Group to create a new overseas medical experience, combining online healthcare with offline overseas medical services.
• DeltaHealth Medical (德达医疗)secondaryStrategic or Co-development Partner · 8 August 2017Strategic agreement signed with DeltaHealth to jointly respond to the 'Healthy China' initiative, combining DeltaHealth's premium medical services with Domo Health's overseas medical resources.
• United Medical (联合医务)coreStrategic or Co-development Partner · 1 August 2017Strategic cooperation signing between Domo Health and United Medical in August 2017. United Medical brings its Hong Kong top-tier medical advantages while Domo Health contributes its Japanese高端医疗服务 expertise, creating a complementary overseas medical service ecosystem.
• Harmony Healthcare (和睦家)secondaryStrategic or Co-development Partner · 1 January 2017Collaboration with Harmony Healthcare to address family infertility concerns, combining domestic premium healthcare with Japanese assisted reproductive and medical services.
• Changsheng Life Insurance (长生人寿保险)coreStrategic or Co-development PartnerChina's first Sino-Japanese joint venture life insurance company provides strategic insurance support for Domo Health's高端客户, offering insurance-backed medical travel services.
• China Southern Airlines (中国南方航空)secondaryGTM or Marketing PartnerPartnership with China Southern Airlines to optimize one-stop services for patients traveling to Japan, potentially including priority booking and coordinated travel arrangements.
• Weiyi Guahao Net (微医挂号网)secondaryTechnology or IntegrationPartnership with Weiyi Guahao Net to build an online-offline integrated medical platform combining internet medical resources with Domo Health's overseas services.
• Shanghai Jiao Tong University Affiliated Tongren Hospital (上海交通大学附属同仁医院)coreStrategic or Co-development PartnerFirst public hospital strategic partner signed by Domo Health in October 2017. Tongren Hospital provides quality outpatient services including specialist consultations, health examinations, and inpatient referrals for Domo Health clients seeking follow-up care in China.
• Wisdom Medical (维世达医疗)secondaryStrategic or Co-development PartnerCross-border medical strategic partnership between Domo Health and Wisdom Medical Holdings group, leveraging their respective strengths in overseas and domestic premium medical services.
• Swiss LACLINIC Anti-Aging Medical Institution (瑞士拉科尼克抗衰老医疗机构)minorStrategic or Co-development PartnerStrategic agreement signed in February 2018 with Swiss LACLINIC to provide Swiss anti-aging medical services to Chinese clients alongside Domo Health's Japanese offerings.
• Noah Wealth (诺亚财富集团)coreGTM or Marketing PartnerPartnership with Noah Wealth Group, a leading wealth management firm, to provide health management services to their high-net-worth client base, including mother's day themed beauty and health exploration programs.
• Tokyo Midtown Medical Center (东京MIDTOWN医疗中心)coreStrategic or Co-development PartnerExclusive partnership with Tokyo Midtown Hospital, described as 'Japan's most luxurious hospital.' The hospital has Japan's most advanced blood purification equipment (one of only 3 machines publicly available in Japan) and over 10,000 blood purification treatment cases. The hospital director served as imperial physician.
• Ginza Health Clinic (银座健康院)coreStrategic or Co-development PartnerGinza Health Clinic is known for的高端精密体检 services and has served prominent clients including Jack Ma. Specializes in comprehensive health examinations and anti-aging treatments.
• Sakakibara Hospital (榊原医院)secondaryStrategic or Co-development PartnerSakakibara Hospital is renowned for cardiovascular disease treatment. Domo Health facilitates referrals for Chinese patients seeking cardiac care and treatment at this institution.
• Helene Clinic (表参道Helene干细胞诊所)coreStrategic or Co-development PartnerA top-tier regenerative medicine clinic in Tokyo's Aoyama area, Helene Clinic specializes in stem cell therapies. Attracts Japanese and international political and entertainment celebrities. Known for cutting-edge stem cell research and treatment.
• Osaka Raffles Hospital (大阪莱福士体检中心)secondaryStrategic or Co-development PartnerOsaka Raffles体检中心, supported by the Raffles Medical Group, offers comprehensive preventive healthcare and diagnostics with premium hotel-like service environment in Osaka's commercial district.
• Tianan Group (天安集团)minorGTM or Marketing PartnerTianan Group partnered with Domo Health to expand health management services to their financial platform clients.
• Ping An Group (平安集团)coreStrategic or Co-development PartnerPing An Group partnered with Domo Health for strategic cooperation, providing insurance and financial support for high-end clients seeking overseas medical services through Ping An's extensive client network.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Saint Lucia Healthcare (盛诺一家): One of the largest Chinese outbound medical tourism agencies, sending patients to Japan, the US, and the UK for cancer treatment and precision checkups. Direct competitor to Domo Health in the China-to-Japan facilitation corridor with overlapping hospital partners and HNW target segment.
• Houpu Fangzhou (厚朴方舟): Chinese medical tourism agency specializing in outbound care to Japan and the US, offering hospital matching, translation, and accompaniment services. Closest functional analog to Domo in the China-Japan corridor with a comparable one-stop service model.
• Medix Global: International medical management and case-navigation company providing cross-border second opinions, treatment coordination, and ongoing care support. Comparable to Domo as a cross-border healthcare facilitator serving affluent patients seeking overseas treatment.
• MORE Health: Cross-border medical consultation platform connecting Chinese patients with US and global specialists for second opinions and treatment planning. Comparable to Domo's remote-consultation and overseas-treatment-coordination offering, with similar HNW patient base.

Broad incumbents

• United Family Healthcare (和睦家): Premium private healthcare network in major Chinese cities with established international medical referral partnerships (also a Domo partner). Competes with Domo domestically on premium checkups and is a partial substitute for outbound medical tourism demand.
• iKang Healthcare Group (爱康国宾): One of China's largest private preventive-health and precision-checkup chains serving affluent urban consumers. Competes with Domo on the domestic precision-examination value proposition and could divert HNW screening demand away from Japan travel.
• Meinian Onehealth (美年大健康): Largest Chinese health checkup chain by network, increasingly focused on premium and specialized examinations. Adjacent competitor in the domestic precision-checkup space and a structural threat if domestic exam quality closes the gap with Japan.
• Raffles Medical Group: Singapore-headquartered international premium healthcare group with China presence and Japan hospital partnerships (also a Domo partner). Competes in the cross-border premium-care market and offers Asian patients an alternative gateway to overseas specialists.

Emerging players

• Chunyu International (春雨国际): Earlier-stage Chinese cross-border medical tourism platform leveraging the Chunyu Doctor user base to refer patients to overseas hospitals. Comparable business model to Domo with a digital-first GTM that competes for inbound HNW inquiries.

Others

• Ping An Good Doctor (平安好医生): Major Chinese digital health platform under Ping An and a strategic partner of Domo. Adjacent ecosystem participant that could disintermediate by building or acquiring its own outbound medical tourism capability, leveraging its captive user base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Domo Health